These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22127965)

  • 1. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
    Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.
    Toh S; Hernández-Díaz S; Logan R; Rossouw JE; Hernán MA
    Ann Intern Med; 2010 Feb; 152(4):211-7. PubMed ID: 20157135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.
    Chlebowski RT; Anderson GL; Manson JE; Schwartz AG; Wakelee H; Gass M; Rodabough RJ; Johnson KC; Wactawski-Wende J; Kotchen JM; Ockene JK; O'Sullivan MJ; Hubbell FA; Chien JW; Chen C; Stefanick ML
    J Natl Cancer Inst; 2010 Sep; 102(18):1413-21. PubMed ID: 20709992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer after use of estrogen plus progestin in postmenopausal women.
    Chlebowski RT; Kuller LH; Prentice RL; Stefanick ML; Manson JE; Gass M; Aragaki AK; Ockene JK; Lane DS; Sarto GE; Rajkovic A; Schenken R; Hendrix SL; Ravdin PM; Rohan TE; Yasmeen S; Anderson G;
    N Engl J Med; 2009 Feb; 360(6):573-87. PubMed ID: 19196674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of breast discomfort among women initiating menopausal hormone therapy.
    Crandall CJ; Markovic D; Huang MH; Greendale GA
    Menopause; 2010; 17(3):462-70. PubMed ID: 20009961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects and safety of a natural oral supplement containing glucosinolates, phytosterols, and citrus flavonoids compared with hormone treatment for the management of postmenopausal symptomatic women: a pilot single-center randomized phase 2 clinical trial.
    Villar-López M; Soto-Becerra P; Chedraui P; Osorio-Manyari JD; Al-Kassab-Córdova A; Osorio-Manyari AA; Fernandez-Sosaya JL; Moya-Silvestre E; Rojas PA; Lugo-Martínez G; Mezones-Holguín E
    Menopause; 2023 Dec; 30(12):1230-1240. PubMed ID: 37874969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy diminishes hearing in peri-menopausal mice.
    Price K; Zhu X; Guimaraes PF; Vasilyeva ON; Frisina RD
    Hear Res; 2009 Jun; 252(1-2):29-36. PubMed ID: 19269311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.
    Chlebowski RT; Anderson GL
    Steroids; 2014 Nov; 90():53-9. PubMed ID: 24910928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy.
    Johnson KC; Aragaki AK; Jackson R; Reiner A; Sandset PM; Rosing J; Dahm AE; Rosendaal F; Manson JE; Martin LW; Liu S; Kuller LH; Cushman M; Rossouw JE
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):418-24. PubMed ID: 26681757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Individualized Homeopathic Medicines in the Treatment of Menopausal Syndrome: Double-Blind, Randomized, Placebo-Controlled Trial.
    Ghosh S; Palanisamy C; Das AD; Mandal S; Guha N; Maiti S; Ghosh P; Singh NK; Koley M; Saha S
    J Integr Complement Med; 2023 Oct; 29(10):649-664. PubMed ID: 37222798
    [No Abstract]   [Full Text] [Related]  

  • 11. Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trials.
    Peila R; Xue X; LaMonte MJ; Shadyab AH; Wactawski-Wende J; Jung SY; Johnson KC; Coday M; Richey P; Mouton CP; Saquib N; Chlebowski RT; Pan K; Michael YL; LeBoff MS; Manson JE; Rohan TE
    Menopause; 2023 Sep; 30(9):898-905. PubMed ID: 37527476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone therapy and central nervous system tumors: Danish nested case-control study.
    Pourhadi N; Meaidi A; Friis S; Torp-Pedersen C; Mørch LS
    PLoS Med; 2023 Dec; 20(12):e1004321. PubMed ID: 38113227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial.
    Veerus P; Fischer K; Hovi SL; Karro H; Rahu M; Hemminki E
    BMC Womens Health; 2008 Mar; 8():5. PubMed ID: 18366766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.
    Hernán MA; Alonso A; Logan R; Grodstein F; Michels KB; Willett WC; Manson JE; Robins JM
    Epidemiology; 2008 Nov; 19(6):766-79. PubMed ID: 18854702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010.
    Jewett PI; Gangnon RE; Trentham-Dietz A; Sprague BL
    Obstet Gynecol; 2014 Oct; 124(4):727-733. PubMed ID: 25198271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization.
    Prior JC; Seifert-Klauss VR; Giustini D; Adachi JD; Kalyan S; Goshtasebi A
    J Musculoskelet Neuronal Interact; 2017 Sep; 17(3):146-154. PubMed ID: 28860416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization.
    Toh S; Hernández-Díaz S; Logan R; Robins JM; Hernán MA
    Epidemiology; 2010 Jul; 21(4):528-39. PubMed ID: 20526200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Contemporary View of Menopausal Hormone Therapy.
    Levy B; Simon JA
    Obstet Gynecol; 2024 Jul; 144(1):12-23. PubMed ID: 38484309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship Explored.
    Lee AW; Wu AH; Wiensch A; Mukherjee B; Terry KL; Harris HR; Carney ME; Jensen A; Cramer DW; Berchuck A; Doherty JA; Modugno F; Goodman MT; Alimujiang A; Rossing MA; Cushing-Haugen KL; Bandera EV; Thompson PJ; Kjaer SK; Hogdall E; Webb PM; Huntsman DG; Moysich KB; Lurie G; Ness RB; Stram DO; Roman L; Pike MC; Pearce CL;
    Epidemiology; 2020 May; 31(3):402-408. PubMed ID: 32028322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of menopausal hormone therapy on COVID-19 severe outcomes in women - A population-based study of the US National COVID Cohort Collaborative (N3C) data.
    Yoshida Y; Chu S; Zu Y; Fox S; Mauvais-Jarvis F;
    Maturitas; 2023 Apr; 170():39-41. PubMed ID: 36773498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.